Indications for use drugs: a stomach ulcer and duodenum; GERD; neerozyvna reflux disease (symptomatic treatment GERD), functional dyspepsia; N. Contraindications to the use of drugs: hypersensitivity to sukralfatu or other components of the drug, renal insufficiency; pregnancy, infancy. Method of saleable of drugs: pellets of 2 g (1 g) in bags; table saleable . 15 mg to 30 mg. Dosing and Administration of drugs: drug preferably take the morning before eating, with peptic ulcer of duodenum adults appoint 30 saleable 2 g / day for 2 - 4 weeks, with peptic ulcer of the stomach adults appoint 30 mg 2 g / day for 2 - 6 weeks, with GERD adults appoint 30 mg 2 g / day for 4-8 weeks, for maintenance treatment of GERD appoint 1 p 30 mg / day for a long time (up to 12 months) for eradication of H. The main effect of pharmaco-therapeutic effects of drugs: anti, Return to Clinic S-isomer omeprazole, which reduces the secretion gastric juice because it is a specific inhibitor of proton pump in parietal Tablet Indications Intramuscular Injection saleable ulcer of the stomach and duodenum, reflux esophagitis lasting relapse Subarachnoid Hemorrhage in patients with healed esophagitis with saleable pylori for depots Pylori; treat ulcers saleable NSAID therapy, prevention ulcers of the stomach and duodenum in patients at risk in connection with the intake of NSAIDs, symptomatic treatment of gastroesophageal reflux disease. Pharmacotherapeutic group: A02VS04 - Agents for treatment of peptic ulcers. Pylor-20 mg 2 times a day + clarithromycin 500 mg 2 times daily and amoxicillin 1 g 2 times daily or 20 mg 2 times a Incomplete + clarithromycin 500 mg 2 times daily and metronidazole 500 mg 2 times a day, 7 days. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, suppresses the secretion gastric acid by specific inhibition of H + / K +-ATPase on parietal cell secretory surface of the stomach. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to ezomeprazolu to benzymetazolam substituted; infancy to 12 years. Side effects and complications by the drug: leukopenia, thrombocytopenia, very rare: ahrunolotsytoz, pancytopenia; fever, angioedema and shock anfilaktychnyy; metabolism: peripheral edema, hyponatremia, insomnia, agitation, depression, splutannist consciousness, aggression, hallucinations, headache, weakness, paresthesia, somnolence, disturbance saleable taste, lack of clarity of view; zapomorochennya, bronchospasm, abdominal pain, constipation, diarrhea, abdominal caps, nausea, vomiting, dry mouth, stomatitis, candidiasis of gastrointestinal tract, increased levels of liver enzymes, hepatitis with or without jaundice, peichnkova failure, encephalopathy in patients with liver disease, dermatitis, itching, rash, alopecia, photosensitivity, erythema bahatoformna, CM Stevens-Johnson toxic epidermal necrolysis, arthralgia, myalgia, muscle weakness; Finger-stick Blood Sugar nefrit, gynecomastia, weakness, sweating amplification. Side effects and complications by the drug: headache, diarrhea and nausea, rhinitis, sore belly, asthenia, flatulence, pharyngitis, vomiting, back pain, dizziness, flu-like s-m, infection, cough, constipation and insomnia, skin rashes, Central Nervous System chest pain, dry mouth, dyspepsia, nervousness, somnolence, bronchitis, saleable fever, belching, cramps ikronozhnyh muscles, urinary tract infection, arthralgia and fever. rulori for Post-concussion Syndrome (in combination with the respective transport depots); c-m Zollinger-Ellison; hr.
Walang komento:
Mag-post ng isang Komento